Skip to main content

Genelux Corp

Exchange: NASDAQSector: HealthcareIndustry: Biotechnology

Genelux Corp

Did you know?

Capital expenditures increased by 188% from FY24 to FY25.

Current Price

$2.85

+4.01%
Profile
Valuation (TTM)
Market Cap$108.45M
P/E-3.37
EV
P/B9.39
Shares Out38.05M
P/Sales
Revenue$0.00
EV/EBITDA

Genelux Corp (GNLX) Dividends

Dividend Overview

Dividend Yield

Dividend / Share

Key Metrics

Market Cap

$108.45M

P/E Ratio

-3.37

Forward P/E

EPS

$-0.86

PEG Ratio

0.44

Book Value

$0.30

Dividend Yield

Profit Margin

ROE

-278.46%

Dividend History

Dividend Safety

GNLX Dividend Analysis

Genelux Corp (GNLX) dividend analysis including yield, payout history, and sustainability metrics.

P/E ratio: -3.37. Free cash flow: $-26.37M. This page shows Genelux Corp's dividend overview, key metrics, historical payout data, and dividend safety assessment to help income-focused investors evaluate the sustainability of dividend payments.

GoodMoat's dividend analyzer evaluates payout ratios, earnings coverage, and free cash flow coverage to determine how well supported Genelux Corp's dividend payments are. Use this analysis alongside the company's financial statements and quality score to make informed income-investing decisions.